We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $357M
1-Year Est. Return 13.97%
This Fund
S&P 500
This Quarter Est. Return
+11.43%
1 Year Est. Return
+13.97%
3 Year Est. Return
+50.79%
5 Year Est. Return
+74.78%
10 Year Est. Return
+368.42%
AUM
$7.36B
AUM Growth
+$457M
Cap. Flow
-$178M
Cap. Flow %
-2.42%
Top 10 Hldgs %
26.1%
Holding
2,906
New
66
Increased
422
Reduced
1,573
Closed
124

Sector Composition

Rank Sector Weight
1 Technology 25.82%
2 Consumer Discretionary 12.47%
3 Healthcare 12.19%
4 Financials 11.52%
5 Communication Services 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NEU icon
1551
NewMarket
NEU
$8.68B
$421K 0.01%
1,229
-78
-6% -$26.9K
LGF.B
1552
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$421K 0.01%
27,345
-398
-1% -$5.58K
ASTE icon
1553
Astec Industries
ASTE
$991M
$419K 0.01%
6,054
PMT
1554
PennyMac Mortgage Investment
PMT
$833M
$419K 0.01%
24,156
-832
-3% -$15.8K
RVMD icon
1555
Revolution Medicines
RVMD
$43.3B
$417K 0.01%
16,548
WABC icon
1556
Westamerica Bancorp
WABC
$1.39B
$415K 0.01%
7,191
NG icon
1557
NovaGold Resources
NG
$3.5B
$415K 0.01%
60,466
-230
-0.4% -$1.68K
MLAB icon
1558
Mesa Laboratories
MLAB
$614M
$415K 0.01%
1,264
ELF icon
1559
e.l.f. Beauty
ELF
$5.5B
$409K 0.01%
12,307
-1,410
-10% -$43.7K
GCP
1560
DELISTED
GCP Applied Technologies Inc.
GCP
$405K 0.01%
12,805
HOPE icon
1561
Hope Bancorp
HOPE
$1.85B
$405K 0.01%
27,559
-3,023
-10% -$44.6K
ENTA icon
1562
Enanta Pharmaceuticals
ENTA
$382M
$405K 0.01%
5,412
VGR
1563
DELISTED
Vector Group Ltd.
VGR
$404K 0.01%
35,211
-17,024
-33% -$182K
SILK
1564
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$404K 0.01%
9,484
SAFE
1565
Safehold
SAFE
$1.09B
$404K 0.01%
3,214
-510
-14% -$62.2K
GBX icon
1566
The Greenbrier Companies
GBX
$1.42B
$403K 0.01%
8,790
IRWD icon
1567
Ironwood Pharmaceuticals
IRWD
$691M
$402K 0.01%
34,516
-3,872
-10% -$47.5K
DVAX
1568
DELISTED
Dynavax Technologies
DVAX
$402K 0.01%
28,581
-616
-2% -$10.1K
PTGX icon
1569
Protagonist Therapeutics
PTGX
$9.91B
$402K 0.01%
11,747
TRS icon
1570
TriMas Corp
TRS
$1.39B
$399K 0.01%
10,791
-1,283
-11% -$44.2K
PLUS icon
1571
ePlus
PLUS
$2.32B
$399K 0.01%
7,410
RPAY icon
1572
Repay Holdings
RPAY
$306M
$399K 0.01%
21,846
OPI
1573
DELISTED
Office Properties Income Trust
OPI
$399K 0.01%
16,061
-25
-0.2% -$642
KOS icon
1574
Kosmos Energy
KOS
$1.52B
$396K 0.01%
114,528
+40,283
+54% +$145K
KALU icon
1575
Kaiser Aluminum
KALU
$2.98B
$396K 0.01%
4,218

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q4 2021 Portfolio in Review

As of Q4 2021, Metropolitan Life Insurance Company (MetLife) held 2,906 positions worth $7.36B, up 6.6% from $6.9B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Metropolitan Life Insurance Company (MetLife)'s Q4 2021 filing shows 66 new, 422 increased, 1,573 reduced and 124 closed positions. Its largest new stake was Kyndryl: 32,951 shares worth $596K. The largest sale was iShares Russell 1000 Growth ETF, an estimated $18.3M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q4 2021 buy was Kyndryl: 32,951 shares worth $596K.
  • Metropolitan Life Insurance Company (MetLife) added most to State Street SPDR S&P 500 ETF Trust in Q4 2021, an estimated $34.8M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q4 2021 reduction was iShares Russell 1000 Growth ETF, cutting an estimated $18.3M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Kansas City Southern in Q4 2021, selling an estimated $3.18M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 26% of its $7.36B portfolio in Q4 2021.
  • Metropolitan Life Insurance Company (MetLife) opened 66 new positions and closed 124 in Q4 2021.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value rose 6.6% quarter-over-quarter to $7.36B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2021, filed 15 Feb 2022.